Company Performance: Revenue, earnings, and profit margins directly impact investor confidence and stock valuation.

Market Sentiment: Overall market optimism or pessimism can influence Opthea's stock price, even without company-specific news.

Clinical Trial Results: Outcomes of Opthea's clinical trials for OPT-302 are crucial. Positive results drive the price up, negative results drive it down.

Regulatory Approvals: Receipt of regulatory approvals for OPT-302 from agencies like the FDA would significantly increase the stock price.

Competition: Progress by competitors in the ophthalmology space, particularly in treatments for wet AMD, affects investor outlook.

Industry Trends: Developments and trends in the biotechnology and pharmaceutical industries impact Opthea's valuation.

Economic Conditions: Macroeconomic factors like interest rates and inflation can influence investor behavior and stock prices.

Analyst Ratings: Recommendations and price targets from financial analysts affect investor perception and trading activity.

News and Events: Announcements regarding partnerships, acquisitions, or other major company events can trigger price fluctuations.

Investor Confidence: Overall confidence in Opthea's management team and strategy plays a role in stock performance.